Effect of natalizumab on B lymphocytes in patients with multiple sclerosis

被引：0
|
作者：
Putzki, N. [1 ]
Kumar, M. [1 ]
Grosse-Wilde, H. [1 ]
Kreuzfelder, E. [1 ]
机构：
[1] Univ Clin Essen, Essen, Germany
来源：
MULTIPLE SCLEROSIS | 2007年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S158 / S158
页数：1
相关论文
共 50 条
  • [21] Natalizumab for multiple sclerosis
    Ransohoff, Richard M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (25): : 2622 - 2629
  • [22] Effect of natalizumab on disease activity in relapsing-remitting multiple sclerosis patients
    Agiela, Mabroka I. M.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (06) : NP5 - NP5
  • [23] The effect of natalizumab therapy on executive function, fatigue and depression in patients with multiple sclerosis
    Jonsdottir, S.
    Hjaltason, H.
    Prainsdottir, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 724 - 724
  • [24] Occurrence of antibodies against natalizumab in relapsing multiple sclerosis patients treated with natalizumab
    Sorensen, Per Soelberg
    Jensen, Poul Erik Hyldgaard
    Haghikia, Aiden
    Lundkvist, Malin
    Vedeler, Christian
    Sellebjerg, Finn
    Koch-Henriksen, Nils
    Fogdell-Hahn, Anna
    Myhr, Kjell-Morten
    Hillert, Jan
    Gold, Ralf
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 (09) : 1074 - 1078
  • [25] Transciptome of B lymphocytes in multiple sclerosis
    Annibali, Viviana
    Umeton, Renato
    Annese, Anita
    Palermo, Antonia
    Mechelli, Rosella
    Policano, Claudia
    Mattei, Gianluca
    Ricigliano, Vito A. G.
    Romano, Silvia
    Coarelli, Giulia
    Ristori, Giovanni
    Salvetti, Marco
    JOURNAL OF NEUROIMMUNOLOGY, 2012, 253 (1-2) : 9 - 9
  • [26] The frequency of occurrence of atypical lymphocytes in peripheral blood smears of natalizumab-treated patients with multiple sclerosis
    Robier, C.
    Amouzadeh-Ghadikolai, O.
    Bregant, C.
    Diez, J.
    Melinz, K.
    Quehenberger, F.
    Quasthoff, S.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2017, 39 (05) : 469 - 474
  • [27] Immune surveillance in multiple sclerosis patients treated with natalizumab
    Stüve, O
    Marra, CM
    Jerome, KR
    Cook, L
    Cravens, PD
    Cepok, S
    Frohman, EM
    Phillips, JT
    Arendt, G
    Hemmer, B
    Monson, NL
    Racke, MK
    ANNALS OF NEUROLOGY, 2006, 59 (05) : 743 - 747
  • [28] Switching from natalizumab to ocrelizumab in patients with multiple sclerosis
    Levin, Seth N.
    Ezuma, Chimere
    Levine, Libby
    Vargas, Wendy S.
    Farber, Rebecca S.
    De Jager, Philip L.
    Riley, Claire S.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (14) : 1964 - 1965
  • [29] Natalizumab in the treatment of patients with multiple sclerosis -: First experience
    Mareckova, Helena
    Havrdova, Eva
    Krasulova, Eva
    Vankova, Zdenka
    Koberova, Michaela
    Sterzl, Ivan
    AUTOIMMUNITY, PT B: NOVEL APPLICATIONS OF BASIC RESEARCH, 2007, 1110 : 465 - 473
  • [30] JCV detection in multiple sclerosis patients treated with natalizumab
    Sadiq, Saud A.
    Puccio, Lauren M.
    Brydon, Edward W. A.
    JOURNAL OF NEUROLOGY, 2010, 257 (06) : 954 - 958
12345